We are still selling the drug actively in the Philippines correct? At one point, one of the big catalyst for the company was the release of data on the “28 patients” in Philippines. Now it’s rarely if at all mentioned.

I realize the sales are not in huge numbers, but we have treated a lot of people for Covid in Philippines over the past 1 to 2 years. Is there a reason we can’t use any of that clinical data? It seems like that market has been completely forgotten about, yet there should be some valuable data – – especially as there has been talk of some meta-analysis.